An encouraging report in the NY Times described a new
collaborative effort involving several major pharmaceutical companies. The
project, called TransCelerate, is intended to make clinical trials more
efficient. It would include attempts to develop standard protocols for trials
and an internet portal for sharing information. In essence, this is a first step
in bringing clinical trials out from behind the walls of corporate secrecy and
into the pre-competitive space. This is a welcome development (if it actually works).
No comments:
Post a Comment